Douglas L. Braunstein, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 100 shares at $60.00 ($6K) on 2019-09-17, disclosed to the SEC on 2019-09-19.
Scheduled sale ($6k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TALK | BUY | 2021-06-24 | $50.0M | — | Filing → |
| HCII | SELL | 2021-04-14 | $0 | — | Filing → |
| EGRX | SELL | 2019-10-15 | $716K | — | Filing → |